Citadel Advisors
TSVT

Citadel Advisors’s 2seventy bio TSVT Stock Holding History

Citadel Advisors’s Portfolio TSVT Stock Details TSVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-7,500
Closed -$37K – 15155
2025
Q1 		$37K Buy
7,500
+4,600
+159% +$14.6K ﹤0.01% 12611
2024
Q4 		$8.53K Sell
2,900
-1,900
-40% -$7.79K ﹤0.01% 13681
2024
Q3 		$22.7K Sell
4,800
-4,900
-51% -$22.1K ﹤0.01% 12688
2024
Q2 		$37.3K Sell
9,700
-18,500
-66% -$83.4K ﹤0.01% 12052
2024
Q1 		$151K Sell
28,200
-26,400
-48% -$124K ﹤0.01% 10756
2023
Q4 		$233K Buy
54,600
+31,500
+136% +$96.8K ﹤0.01% 9644
2023
Q3 		$90.6K Buy
23,100
+20,800
+904% +$136K ﹤0.01% 11018
2023
Q2 		$23.3K Sell
2,300
-2,500
-52% -$26.5K ﹤0.01% 12601
2023
Q1 		$49K Sell
4,800
-8,264
-63% -$94.5K ﹤0.01% 12176
2022
Q4 		$122K Buy
+13,064
New +$184K ﹤0.01% 10924
2022
Q1 		– Sell
-12,870
Closed -$330K – 14596
2021
Q4 		$330K Buy
+12,870
New +$401K ﹤0.01% 10720

Other funds holding TSVT

N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Citadel Advisors's TSVT Position: Q1 2025 in Review

Citadel Advisors sold out of 2seventy bio (TSVT) in Q1 2025, closing a stake of 12,318 shares — an estimated $39.1K sold.

Citadel Advisors first reported a position in TSVT in Q2 2022 and held it in 11 quarters. The position peaked at $24.1M in Q1 2023. 139 funds tracked by Wall St. Rank hold TSVT as of Q1 2025.

  • Citadel Advisors reported no remaining 2seventy bio position as of Q1 2025 after selling out during the quarter.
  • Citadel Advisors sold 12,318 2seventy bio shares in Q1 2025, an estimated $39.1K.
  • Citadel Advisors first reported a position in 2seventy bio in Q2 2022 and held it in 11 quarters.
  • Citadel Advisors's 2seventy bio position peaked at $24.1M in Q1 2023.
  • 139 funds tracked by Wall St. Rank held 2seventy bio as of Q1 2025.

Based on Citadel Advisors's 13F filing for Q1 2025, filed 15 May 2025.